Catalyst Wire Dossier Catalyst Wire Dossier

bufexamac

bufexamac
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bufexamac, covering 2010-04-22 to 2010-04-22. Get the full timeline:

Most recent: European Medicines Agency recommends revocation of marketing authorisations for bufexamac

See pricing